Related Experiment Video
Updated: May 31, 2026
11:07
Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
Published on: September 21, 2011
Novel hyperactive glucocorticoid receptor isoform identified within a human population
Kelly Tung1, Aaron C Baker, Amir Amini
1Department of Surgery, University of California, Davis, Sacramento, California, USA.
Shock (Augusta, Ga.)
|June 25, 2011
Summary
Novel human glucocorticoid receptor (hGR) isoforms impact steroid therapy response. A hyperactive isoform, hGR NS-1, shows over double the activity of the standard hGR NCBI, explaining unpredictable glucocorticoid treatment outcomes.
Area of Science:
- Endocrinology
- Molecular Biology
- Pharmacogenomics
Background:
- Glucocorticoids are vital anti-inflammatory drugs, but their efficacy, particularly in severe conditions like septic shock, is unpredictable.
- Existing research links specific human glucocorticoid receptor (hGR) isoforms to diminished steroid treatment responses.
- Investigating diverse hGR isoforms may elucidate the variability in patient responses to glucocorticoid therapy.
Purpose of the Study:
- To characterize novel human glucocorticoid receptor (hGR) isoforms and their functional impact on steroid response.
- To identify specific genetic variations within hGR that contribute to differential transactivation activity.
- To understand the molecular basis for the unpredictable clinical efficacy of glucocorticoids.
Main Methods:
- Analysis of hGR isoforms in blood samples from 97 human volunteers.
- Measurement of transactivation potentials using luciferase reporter assays.
- Creation and testing of synthetic constructs to pinpoint single nucleotide polymorphisms (SNPs) responsible for altered receptor activity.
Main Results:
- A novel isoform, hGR NS-1, exhibited over twice the transactivation activity of the reference hGR NCBI.
- Another isoform, hGR DL-1, showed less than 10% of hGR NCBI activity, with a truncated protein structure.
- A specific SNP within the ligand-binding domain of hGR NS-1 was identified as the primary driver of its hyperactivity.
- hGR NS-1 demonstrated a significantly greater dose-dependent response to hydrocortisone compared to hGR NCBI.
Conclusions:
- The newly identified hyperactive hGR NS-1 isoform offers a potential explanation for the variable clinical responses observed with glucocorticoid therapy.
- Understanding hGR isoform variations, such as hGR NS-1, is crucial for optimizing steroid treatment strategies.
- Pharmacogenomic analysis of hGR variants could lead to more predictable and effective anti-inflammatory treatments.
Related Concept Videos
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...